Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus (SAMS12)
This study has been completed.
Study NCT00495885   Information provided by Sanofi-Aventis
First Received: July 2, 2007   Last Updated: September 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Dyssomnias
Endocrine System Diseases
Glucose Metabolism Disorders
Mental Disorders
Metabolic Diseases
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
volinanserin (M100907)
Placebo
Additional drug interventions recognized in this trial
MDL 100907
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Antagonists
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services